Philip Morris International Inc. (PM)
Philip Morris: Balanced Risk With Smoke-Free Transition
We initiate Philip Morris International Inc. at Hold with a $170 target, citing strong smoke-free momentum but stretched valuation versus peers. Operational execution—especially ZYN and IQOS scaling—drives above-consensus EPS forecasts, with cost savings and mix shift fueling margin expansion. Supply chain constraints and regulatory risks could cap upside, making capacity execution and policy developments key swing factors for the stock.
Philip Morris: The Easy Money Has Been Made (Rating Downgrade)
Philip Morris has outperformed the market and tech giants over 5 years, driven by strong growth in smoke-free products like ZYN and IQOS. Despite impressive financial results and a successful smoke-free transition, I am downgrading my rating to neutral, due to limited upside and a lower dividend yield. PM now trades at a premium valuation with a sub-3% yield, making alternatives like MO, VZ, and growth stocks more attractive for new capital allocation.
Philip Morris: ZYN And IQOS Are Killing The 'Tobacco Is Dead' Myth
Philip Morris International's transformation to smoke-free products like ZYN and IQOS drives strong growth, higher margins, and outperformance, versus traditional tobacco peers. Despite a lower dividend yield than competitors, PM's capital appreciation and consistent dividend growth make it a superior long-term investment. Valuation is elevated at a 25.8x P/E, but justified by double-digit EPS growth, industry-leading profitability, and a future-proof product portfolio.
Philip Morris' Valuation Looks Overstretched: Time to Hit Pause?
PM's smoke-free pivot fuels a 50% rally, but its stretched valuation may signal a pause for investors.
2 Red-Hot Stocks Suited for Momentum Investors
Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions are present. And that's precisely what these companies have seen over recent months thanks to strong quarterly results.
Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?
Philip Morris International PM continues to lean on pricing as a key earnings driver. The company delivered a strong first quarter of 2025, with adjusted earnings per share (EPS) rising 12.7% year over year to $1.69.
Stocks rally on hopes Israel-Iran conflict will subside, Phillip Morris stock hits records
Asking for a Trend anchor Josh Lipton breaks down the latest market trends for June 16, 2025. US stocks close higher on hopes the Israel-Iran conflict remains contained.
Bull of the Day: Philip Morris Intl (PM)
Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.
ZYN and IQOS Scale Up: Is Philip Morris Leading the Industry Reset?
PM sees smoke-free products drive 44% of Q1 profit as ZYN and IQOS momentum redefines its future beyond tobacco.
Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?
PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.
Philip Morris International, Inc. (PM) dbAccess Global Consumer Conference Call Transcript
Philip Morris International, Inc. (NYSE:PM ) dbAccess Global Consumer Conference Call June 3, 2025 5:15 AM ET Company Participants Emmanuel Babeau - CFO Conference Call Participants Damian McNeela - Deutsche Bank Damian McNeela Good morning, everybody. I think we will make a start.
This Isn't The Philip Morris You Think It Is
Philip Morris is leading the industry transition to smoke-free products, with 42% of revenue now from alternatives like IQOS and Zyn. Strong Q1 2025 results—10.2% organic revenue growth, rising margins, and raised earnings guidance—demonstrate robust financial health and execution. Despite a premium valuation and some regulatory and competitive risks, PM's stable cash flow and dividend growth justify a strong buy rating.
